Cargando…

Metabolic modeling-based drug repurposing in Glioblastoma

The manifestation of intra- and inter-tumor heterogeneity hinders the development of ubiquitous cancer treatments, thus requiring a tailored therapy for each cancer type. Specifically, the reprogramming of cellular metabolism has been identified as a source of potential drug targets. Drug discovery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomi-Andrino, Claudio, Pandele, Alina, Winzer, Klaus, King, John, Rahman, Ruman, Kim, Dong-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249780/ https://www.ncbi.nlm.nih.gov/pubmed/35778411 http://dx.doi.org/10.1038/s41598-022-14721-w

Ejemplares similares

Physicochemical and metabolic constraints for thermodynamics-based stoichiometric modelling under mesophilic growth conditions
por: Tomi-Andrino, Claudio, et al.
Publicado: (2021)

A genome-scale metabolic model of Cupriavidus necator H16 integrated with TraDIS and transcriptomic data reveals metabolic insights for biotechnological applications
por: Pearcy, Nicole, et al.
Publicado: (2022)

Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Required Gene Set for Autotrophic Growth of Clostridium autoethanogenum
por: Woods, Craig, et al.
Publicado: (2022)

EPEN-43. TARGETING INTRA-TUMOUR HETEROGENEITY IN PAEDIATRIC EPENDYMOMA: AN INTEGRATED OMICS STUDY TOWARDS PATIENT-TAILORED THERAPY
por: Pandele, Alina, et al.
Publicado: (2020)

From GWAS to drug screening: repurposing antipsychotics for glioblastoma
por: Lin, Wei-Zhi, et al.
Publicado: (2022)

An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
por: Lyne, Seán B., et al.
Publicado: (2021)

Integrated Metabolomics and Transcriptomics Using an Optimised Dual Extraction Process to Study Human Brain Cancer Cells and Tissues
por: Woodward, Alison, et al.
Publicado: (2021)

Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
por: Harder, Bryan G., et al.
Publicado: (2018)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020)

Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature
por: Alomari, Safwan, et al.
Publicado: (2021)

Against Repurposing Methadone for Glioblastoma Therapy
por: Vatter, Tatjana, et al.
Publicado: (2020)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma
por: Ntafoulis, Ioannis, et al.
Publicado: (2022)

Drug Repurposing of Metabolic Agents in Malignant Glioma
por: Seliger, Corinna, et al.
Publicado: (2018)

Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS
por: He, Wenshi, et al.
Publicado: (2023)

Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations
por: Vasey, Catherine E., et al.
Publicado: (2021)

Electric field responsive nanotransducers for glioblastoma
por: Jain, Akhil, et al.
Publicado: (2022)

Repurposing Clemastine to Target Glioblastoma Cell Stemness
por: Sun, Michael A., et al.
Publicado: (2023)

Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potential
por: Smith, Stuart James, et al.
Publicado: (2020)

Towards the network-based prediction of repurposed drugs using patient-specific metabolic models
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
por: Kast, Richard E, et al.
Publicado: (2017)

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
por: Jones, Dylan, et al.
Publicado: (2022)

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma
por: Bintener, Tamara, et al.
Publicado: (2023)

Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021)

Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Gsmodutils: a python based framework for test-driven genome scale metabolic model development
por: Gilbert, James, et al.
Publicado: (2019)

Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021)

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
por: Timmons, James A, et al.
Publicado: (2022)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Drug-Repurposing Strategy for Dimethyl Fumarate
por: Giunta, Salvatore, et al.
Publicado: (2023)

Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma
por: McGowan, Erin, et al.
Publicado: (2023)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Network-based drug repurposing for HPV-associated cervical cancer
por: Ahmed, Faheem, et al.
Publicado: (2023)

Transcription Profile and Pathway Analysis of the Endocannabinoid Receptor Inverse Agonist AM630 in the Core and Infiltrative Boundary of Human Glioblastoma Cells
por: Williams, Gareth, et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d9kl91a6vucrltfm9mvuv6av3m